Human Chorionic Gonadotropin is an ideal target for immuno-contraception, development of a potential birth control vaccine with additional use for immunotherapy of advanced stage cancers | ||
| dc.conicet.organizacion | Talwar Foundation | |
| dc.conicet.organizacion | Texas Biomedical Research Institute. Department of Virology and Immunology | |
| dc.conicet.organizacion | Talwar Foundation | |
| dc.conicet.organizacion | Talwar Foundation | |
| dc.conicet.organizacion | Texas Biomedical Research Institute. Department of Virology and Immunology | |
| dc.conicet.organizacion | Alpha Diagnostic International | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental | |
| dc.contributor.author | Talwar, G. P. | |
| dc.contributor.author | Gupta, J. C. | |
| dc.contributor.author | Hada, R. S. | |
| dc.contributor.author | Nand, N. K. | |
| dc.contributor.author | Vyas, S. P. | |
| dc.contributor.author | Vyas, H. K. | |
| dc.contributor.author | Rulli, Susana Beatriz | |
| dc.date.issued | 2016 | |
| dc.description.abstract | The making of initial and progressively better, more immunogenic vaccines against hCG is briefly reviewed. Phase I Clinical trials in India, Finland, Sweden, Chile and Brazil have shown the safety and reversibility of the vaccine. Phase II trials have shown that anti-hCG antibodies above 50ng/ml titres prevent pregnancy in sexually active women without impairment of ovulation and derangement of menstrual regularity. A recombinant anti-hCG has been developed, which is expressed as DNA and protein. Priming with DNA followed by proteinic boosters of the vaccine induces very high titres of antihCG antibodies in mice. Extensive toxicology studies in rodent and marmosets have shown the safety of the recombinant vaccine. Besides contraception, the vaccine may find applications in therapy of terminal drugs-resistant cancers expressing hCG ectopically. | es |
| dc.description.fil | Fil: Talwar, G. P.. Talwar Foundation; India | |
| dc.description.fil | Fil: Gupta, J. C.. Texas Biomedical Research Institute. Department of Virology and Immunology; India | |
| dc.description.fil | Fil: Hada, R. S.. Talwar Foundation; India | |
| dc.description.fil | Fil: Nand, N. K.. Talwar Foundation; India | |
| dc.description.fil | Fil: Vyas, S. P.. Texas Biomedical Research Institute. Department of Virology and Immunology; India | |
| dc.description.fil | Fil: Vyas, H. K.. Alpha Diagnostic International; Estados Unidos | |
| dc.description.fil | Fil: Rulli, Susana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Talwar, G. P.; Gupta, J. C.; Hada, R. S.; Nand, N. K.; Vyas, S. P.; et al.; Human Chorionic Gonadotropin is an ideal target for immuno-contraception, development of a potential birth control vaccine with additional use for immunotherapy of advanced stage cancers; Austin Publishing Group; Austin Journal of Obstetrics and Gynecology; 3; 2; 2016; 1-6 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2378-1386 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/255737 | |
| dc.journal.ciudad | Irving | es |
| dc.journal.number | 2 | es |
| dc.journal.pagination | 1-6 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Austin Journal of Obstetrics and Gynecology | es |
| dc.journal.volume | 3 | es |
| dc.language.iso | eng | es |
| dc.publisher | Austin Publishing Group | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://austinpublishinggroup.com/obstetrics-gynecology/fulltext/ajog-v3-id1059.php | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | PREVENTION OF PREGNANCY | es |
| dc.subject | ECTOPIC EXPRESSION OF hCG IN CANCERS | es |
| dc.subject | HCG-β-TT | es |
| dc.subject | VACCINE | es |
| dc.subject.classification | Patología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Human Chorionic Gonadotropin is an ideal target for immuno-contraception, development of a potential birth control vaccine with additional use for immunotherapy of advanced stage cancers | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.d78cb147-6584-48af-bdca-ab869dcb238b_B.pdf
- Tamaño:
- 3.54 MB
- Formato:
- Adobe Portable Document Format